Dupixent (sanofi-aventis U.S. LLC)
Welcome to the PulseAid listing for the Dupixent drug offered from sanofi-aventis U.S. LLC. This Interleukin-4 Receptor alpha Antagonist [EPC],Interleukin 4 Receptor alpha Antagonists [MoA],Antibodies, Monoclonal [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | sanofi-aventis U.S. LLC |
| NON-PROPRIETARY NAME: | Dupilumab |
| SUBSTANCE NAME: | DUPILUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Interleukin-4 Receptor alpha Antagonist [EPC],Interleukin 4 Receptor alpha Antagonists [MoA],Antibodies, Monoclonal [Chemical/Ingredient] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2017-03-28 |
| END MARKETING DATE: | 0000-00-00 |
Dupixent HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dupixent from sanofi-aventis U.S. LLC |
| LABELER NAME: | sanofi-aventis U.S. LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/2mL) |
| START MARKETING DATE: | 2017-03-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0024-5914_e23c3c02-6f3f-425f-925a-781b74e979bc |
| PRODUCT NDC: | 0024-5914 |
| APPLICATION NUMBER: | BLA761055 |
Other DUPILUMAB Pharmaceutical Manufacturers / Labelers:
